AtriCure (ATRC) Cash from Financing Activities (2010 - 2026)

AtriCure (ATRC) has reported Cash from Financing Activities for 17 consecutive years, with $3.3 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash from Financing Activities fell 4.59% year-over-year to $3.3 million; the TTM figure through Jun 2026 stood at -$1.9 million (up 65.26% YoY), while the FY2025 annual figure was $1.2 million, up 132.64% from the prior year.
• Cash from Financing Activities grew to $3.3 million in Q2 2026 per ATRC's latest filing, from -$13.3 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $6.0 million in Q3 2025 and bottomed at -$13.3 million in Q1 2026.
• Historically, Cash from Financing Activities has averaged -$1.1 million across 5 years, with a median of $1.8 million in 2022.
• Annual changes were most pronounced in 2024 — Cash from Financing Activities plunged 352.27% — and 2025, when it soared 1897.0%.
• AtriCure's Cash from Financing Activities stood at $2.0 million in 2022, then increased by 19.02% to $2.4 million in 2023, then fell by 26.32% to $1.7 million in 2024, then grew by 20.71% to $2.1 million in 2025, then jumped by 55.48% to $3.3 million in 2026.
• Business Quant data shows ATRC's Cash from Financing Activities at $3.3 million in Q2 2026, -$13.3 million in Q1 2026, and $2.1 million in Q4 2025.